Analysen von James Gordon
| 20.06.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.06.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.05.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.05.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 15.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 13.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.03.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 13.03.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 27.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 02.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.01.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.01.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.01.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 15.01.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.12.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.12.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 30.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.11.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 07.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 03.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 27.10.17 | GSK neutral | JP Morgan Chase & Co. | |
| 25.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.10.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 02.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.09.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 14.09.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 06.09.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 09.08.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.08.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 31.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 25.07.17 | GSK Neutral | JP Morgan Chase & Co. | |